Bortezomib: the current APEX of treatment for multiple myeloma?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1493, 2005-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide - most significant drug in decades for multiple myeloma?

Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Bortezomib in multiple myeloma

By Terpos Evangelos Roussou Maria Dimopoulos Meletios-Athanassios

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 639-654

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib for multiple myeloma

By Popat Rakesh Joel Simon Oakervee Heather Cavenagh Jamie

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. : 1337-1346

Informa Healthcare

Access to resources Recommend Favorite

Results of the first bortezomib-based induction therapy in the treatment of multiple myeloma

By Kortüüm Martin Einsele Hermann

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1661-1663

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib: Thrombocytopenia?: case report

Reactions Weekly, Vol. 1, Iss. 1322, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite